Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy.

Weisler R, McIntyre RS, Bauer M.

Expert Rev Neurother. 2013 Nov;13(11):1183-200. doi: 10.1586/14737175.2013.846519. Review.

PMID:
24175721
2.

The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder.

Weisler R, McIntyre RS.

Expert Rev Neurother. 2013 Nov;13(11):1161-82. doi: 10.1586/14737175.2013.846520. Review.

PMID:
24175720
3.

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.

El-Khalili N, Joyce M, Atkinson S, Buynak RJ, Datto C, Lindgren P, Eriksson H.

Int J Neuropsychopharmacol. 2010 Aug;13(7):917-32. doi: 10.1017/S1461145710000015. Epub 2010 Feb 23.

PMID:
20175941
4.

Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.

Katila H, Mezhebovsky I, Mulroy A, Berggren L, Eriksson H, Earley W, Datto C.

Am J Geriatr Psychiatry. 2013 Aug;21(8):769-84. doi: 10.1016/j.jagp.2013.01.010. Epub 2013 Feb 6.

PMID:
23567397
5.

Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.

Liebowitz M, Lam RW, Lepola U, Datto C, Sweitzer D, Eriksson H.

Depress Anxiety. 2010 Oct;27(10):964-76. doi: 10.1002/da.20740.

PMID:
20734365
6.

Quetiapine XR: current status for the treatment of major depressive disorder.

Pae CU, Sohi MS, Seo HJ, Serretti A, Patkar AA, Steffens DC, Masand PS.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1165-73. doi: 10.1016/j.pnpbp.2010.03.023. Epub 2010 Mar 20. Review.

PMID:
20307622
7.

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.

Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA.

J Affect Disord. 2013 Oct;151(1):209-19. doi: 10.1016/j.jad.2013.05.079. Epub 2013 Jun 27.

PMID:
23810357
8.

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.

Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group.

CNS Spectr. 2009 Jun;14(6):299-313.

PMID:
19668121
9.

Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder.

Locklear JC, Svedsäter H, Datto C, Endicott J.

J Affect Disord. 2013 Jul;149(1-3):189-95. doi: 10.1016/j.jad.2013.01.021. Epub 2013 Apr 29.

PMID:
23639212
10.

Quetiapine extended release: adjunctive treatment in major depressive disorder.

Sanford M.

CNS Drugs. 2011 Sep 1;25(9):803-13. doi: 10.2165/11207280-000000000-00000. Review.

PMID:
21870891
11.

Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.

Weisler RH, Montgomery SA, Earley WR, Szamosi J, Lazarus A.

Int Clin Psychopharmacol. 2012 Jan;27(1):27-39. doi: 10.1097/YIC.0b013e32834d6f91.

PMID:
22027845
12.

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.

Bauer M, Demyttenaere K, El-Khalili N, Thase ME, Papakostas GI, Szamosi J, Earley WR, Eriksson H.

Int Clin Psychopharmacol. 2014 Jan;29(1):16-25. doi: 10.1097/YIC.0000000000000011.

PMID:
24108148
13.

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.

Bortnick B, El-Khalili N, Banov M, Adson D, Datto C, Raines S, Earley W, Eriksson H.

J Affect Disord. 2011 Jan;128(1-2):83-94. doi: 10.1016/j.jad.2010.06.031. Epub 2010 Aug 6.

PMID:
20691481
14.

Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.

Weisler R, Montgomery SA, Earley WR, Szamosi J, Eriksson H.

J Clin Psychiatry. 2014 May;75(5):520-7. doi: 10.4088/JCP.13m08624.

PMID:
24816198
15.

A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.

Bauer M, El-Khalili N, Datto C, Szamosi J, Eriksson H.

J Affect Disord. 2010 Dec;127(1-3):19-30. doi: 10.1016/j.jad.2010.08.032. Epub 2010 Sep 29. Review.

PMID:
20884063
16.

Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.

McIntyre RS, Muzina DJ, Adams A, Lourenco MT, Law CW, Soczynska JK, Woldeyohannes HO, Nathanson J, Kennedy SH.

Expert Opin Pharmacother. 2009 Dec;10(18):3061-75. doi: 10.1517/14656560903448837. Review.

PMID:
19954275
17.

Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder.

Vieta E, Bauer M, Montgomery S, McIntyre RS, Szamosi J, Earley WR, Eriksson H.

J Affect Disord. 2013 Sep 5;150(2):639-43. doi: 10.1016/j.jad.2013.01.052. Epub 2013 Mar 14.

PMID:
23497790
18.

A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder.

Khan A, Joyce M, Atkinson S, Eggens I, Baldytcheva I, Eriksson H.

J Clin Psychopharmacol. 2011 Aug;31(4):418-28. doi: 10.1097/JCP.0b013e318224864d.

PMID:
21694613
19.

Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.

Bauer M, McIntyre RS, Szamosi J, Eriksson H.

Int J Neuropsychopharmacol. 2013 Sep;16(8):1755-65. doi: 10.1017/S146114571300031X. Epub 2013 May 14.

PMID:
23672772
20.

Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.

Sheehan DV, Locklear J, Svedsäter H, Datto C.

Int Clin Psychopharmacol. 2012 Sep;27(5):239-48. doi: 10.1097/YIC.0b013e328356ac78.

PMID:
22859063

Supplemental Content

Support Center